SBUX vs TARS · P/E 76, rev $37.18B vs rev $336.0M
Starbucks Corporation (SBUX) versus Tarsus Pharmaceuticals Inc (TARS) — a side-by-side from cached financials, not a winner call.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian R. Niccol.
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Latest reported TARS revenue for 2026-06-30 was $336.0M. Net income was -$25.5M. TARS currently screens at market cap $2.66B.
SBUX currently screens at market cap $113.76B and trailing P/E 76.2. TARS currently screens at market cap $2.66B.
Not investment advice. Open the SBUX and TARS stock pages for the full models.
Not investment advice.